Evidence map›Paper›PMID 19551406›Full record

ArticleJournal of cancer research and clinical oncology2009

DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells.

Shuang Bing Xu, Xiao Hong Liu, Ben Hui Li, Yan Zhang, Jia Yuan, Qin Yuan, Pin Dong Li, Xian Zi Yang, Feng Li, Wen Jie Zhang

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of cancer research and clinical oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. SHP-1: the next checkpoint target for cancer immunotherapy?Biochemical Society transactions · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shuang Bing XuLaboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, 832002 Shehezi, Xinjiang, China.
Xiao Hong Liu
Ben Hui Li
Yan Zhang
Jia Yuan
Qin Yuan
Pin Dong Li
Xian Zi Yang
Feng Li
Wen Jie Zhang
Shihezi University · CNTaihe Hospital · CNXiangyang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeStat6 signaling is active in cancer cells and IL-4-induced Stat6 activities or Stat6 activational phenotypes vary among cancer cells. This study aimed at investigating possible mechanism(s) involved in the formation of varying Stat6 activities/phenotypes.

methodsStat6 regulatory genes, SOCS-1 and SHP-1, were examined for mRNA expression using RT-PCR, and their promoter DNA methylation was assayed by methylation-specific PCR in Stat6-phenotyped colon cancer cell lines. DNA methylation was then verified by sequencing. RT-PCR assay and Western blotting were used to detect the expression of SOCS-1 and SHP-1 after demethylation using 5-aza-2'-deoxycytidine.

resultsCompared with Stat6(null) Caco-2 cells, Stat6(high) HT-29 cells showed decreased constitutive expression of SOCS-1 and SHP-1, which correlated with DNA hypermethylation in these genes' promoters. Interestingly, demethylation in HT-29 cells recovered the constitutive expression of SOCS-1 and SHP-1.

conclusionsThese findings suggest that DNA methylation controls the constitutive expression of negative Stat6 regulatory genes, which may affect Stat6 activities.

Indexed as

Antimetabolites, AntineoplasticAzacitidineCaco-2 CellsColonic NeoplasmsDecitabineDNA MethylationGene Expression Regulation, NeoplasticHT29 CellsHumansInterleukin-4PhenotypeProtein Tyrosine Phosphatase, Non-Receptor Type 6STAT6 Transcription FactorSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling ProteinsAntimetabolites, AntineoplasticAzacitidineDecitabineIL4 protein, humanInterleukin-4Protein Tyrosine Phosphatase, Non-Receptor Type 6PTPN6 protein, humanSOCS1 protein, humanSTAT6 protein, humanSTAT6 Transcription FactorSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling Proteins

Identifiers

PMID19551406
PMCPMC11844784
OpenAlexW1994908849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.